Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone vs Dydrogesterone + HCG in Threatened Miscarriage
NCT07608133Completed
- Sponsor
- PAF Hospital Islamabad
- Start
- Dec 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Randomised, open-label trial of human chorionic gonadotrophin in threatened miscarriage (2 arms), sponsored by PAF Hospital Islamabad. Primary endpoint: Number of Participants with Treatment Success at 14 days. Started Dec 2025; status: completed.
02
Drugs
human chorionic gonadotrophin
03
Conditions
threatened miscarriage
Beyond the preview
Go deeper on NCT07608133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07608133.